The cutoff value and prognosis of anti-PLA2R antibody for idiopathic membranous nephropathy: a single-center retrospective study in China

The cutoff value and prognosis of anti-PLA2R antibody for idiopathic membranous nephropathy: a single-center retrospective study in China

AbstractSerum anti-phospholipase A2 receptor (anti-PLA2R) antibody is used for the noninvasive diagnosis of idiopathic membranous nephropathy (IMN). However, the cutoff value of anti-PLA2R antibodies in IMN patients is debatable. This study aimed to investigate the cutoff value of anti-PLA2R antibod...

Full description

Bibliographic Details
Main Authors:	Hongxia Guo, Yao Yao, Jiansuo Zhou, Song Wang, Yue Wang, Danxia Zheng
Format:	Article
Language:	English
Published:	Taylor & Francis Group 2023-12-01
Series:	Renal Failure
Subjects:	Cutoff value anti-PLA2R antibody idiopathic membranous nephropathy diagnosis prognosis
Online Access:	https://www.tandfonline.com/doi/10.1080/0886022X.2023.2253922

Similar Items

Clinical features, course and prognosis of idiopathic membranous nephropathy depending on the presence of antibodies against M-type phospholipase A2 receptor
by: Elías Jatem Escalante, et al.
Published: (2015-09-01)

Containing anti-PLA2R IgG antibody induces podocyte injury in idiopathic membranous nephropathy
by: Ying Zhang, et al.
Published: (2023-12-01)

Relationship between renal tissues phospholipase A2 receptor and its serum antibody and clinical condition and prognosis of idiopathic membranous nephropathy: a meta-analysis
by: Dan Dong, et al.
Published: (2019-12-01)

The application of podocyte antigen PLA2R and anti-PLA2R antibody in the diagnosis and treatment of membranous nephropathy
by: Yang Chen, et al.
Published: (2023-12-01)

Association of serum mannose-binding lectin, anti-phospholipase A2 receptor antibody and renal outcomes in idiopathic membranous nephropathy and atypical membranous nephropathy: a single center retrospective cohort study
by: Yuchao Zhao, et al.
Published: (2022-12-01)

The Prognostic Value of Anti-PLA2R Antibodies Levels in Primary Membranous Nephropathy
by: Olga Lesya Kukuy, et al.
Published: (2023-05-01)

Anti-phospholipase A2 receptor antibody levels at diagnosis predicts outcome of TAC-based treatment for idiopathic membranous nephropathy patients
by: Bihua Wang, et al.
Published: (2022-09-01)

Analysis of glomerular PLA2R efficacy in evaluating the prognosis of idiopathic membranous nephropathy in the background of different serum anti-PLA2R levels
by: Yuemeng Sun, et al.
Published: (2022-12-01)

Phospholipase A2 Receptor Antibodies and Clinical Prognosis in Patients with Idiopathic Membranous Nephropathy: An Updated Systematic Review and Meta-Analysis
by: Jialing Zhang, et al.
Published: (2023-01-01)

Acute kidney injury in patients with idiopathic membranous nephropathy: influencing factors and prognosis
by: Zhenzhou Li, et al.
Published: (2023-12-01)

Clinicopathological features and prognosis of idiopathic membranous nephropathy with thyroid dysfunction
by: Peiheng Wang, et al.
Published: (2023-03-01)

Baseline proteinuria level is associated with prognosis in idiopathic membranous nephropathy
by: Xinxin Chen, et al.
Published: (2019-01-01)

VEGFA promotes the occurrence of PLA2R-associated idiopathic membranous nephropathy by angiogenesis via the PI3K/AKT signalling pathway
by: Ben Ke, et al.
Published: (2022-09-01)

Urinary protein and renal prognosis in idiopathic membranous nephropathy: a multicenter retrospective cohort study in Japan
by: Makoto Yamaguchi, et al.
Published: (2018-10-01)

An Evaluation of the Level of Anti-phospholipase A2 Receptor (PLA2R) Antibody in Different Pathological Types of Glomerulonephritis
by: F Sadadi, et al.
Published: (2017-02-01)

Temporal Association Between PLA2R Antibodies and Clinical Outcomes in Primary Membranous Nephropathy
by: R. Ramachandran, et al.
Published: (2018-01-01)

The elevated levels of urinary angiotensinogen are correlated with the severity of idiopathic membranous nephropathy
by: Ziyong Tang, et al.
Published: (2018-12-01)

Phospholipase A2 receptor (PLA2R) related membranous nephropathy - not specific for idiopathic cases any more
by: Bahar Bastani
Published: (2018-01-01)

Thrombotic thrombocytopenic purpura developed during the conservative treatment of anti-phospholipase A2 receptor antibody-positive idiopathic membranous nephropathy: a case report
by: Rei Iio, et al.
Published: (2020-10-01)

The Role of Renal PLA2R Staining Combined with Serum PLA2R Antibody in Membranous Nephropathy Risk Stratification
by: Xiaofan Hu, et al.
Published: (2023-12-01)

Lectin Complement Pathway Activation is Associated with Massive Proteinuria in PLA2R-Positive Membranous Nephropathy: A Retrospective Study
by: Li J, et al.
Published: (2023-05-01)

Clinicopathological and prognostic characteristics of idiopathic membranous nephropathy with dual antigen positivity
by: Lei Yang, et al.
Published: (2024-01-01)

Factors affecting the long-term outcomes of idiopathic membranous nephropathy
by: Hyuk Huh, et al.
Published: (2017-03-01)

High-cutoff hemodialysis in multiple myeloma patients with acute kidney injury
by: Yan Xing, et al.
Published: (2022-10-01)

Effect of Glomerular Mannose-Binding Lectin Deposition on the Prognosis of Idiopathic Membranous Nephropathy
by: Ying Zhang, et al.
Published: (2020-09-01)

Phospholipase A2 Receptor Antibody IgG4 Subclass Improves Sensitivity and Specificity in the Diagnosis of Idiopathic Membranous Nephropathy
by: Biao Huang, et al.
Published: (2019-06-01)

Horseshoe kidney with PLA2R-positive membranous nephropathy
by: Shuai-Shuai Shi, et al.
Published: (2021-08-01)

Clinical characteristics and prognosis of patients with idiopathic membranous nephropathy with kidney tubulointerstitial damage
by: Mengyao Sun, et al.
Published: (2023-12-01)

Idiopathic multicentric Castleman disease with Sjögren’s syndrome and secondary membranous nephropathy: a case report and review of the literature
by: Yuejuan Pan, et al.
Published: (2020-12-01)

The Analysis of Clinicopathological Characters and Short-term Prognosis in Idiopathic Membranous Nephropathy Patients with Immunoglobulin G4 Combined with Other Different Immunoglobulin G Subtypes Deposition
by: SUN Shuaigang, SHENG Xiaoxiao, ZHANG Wenhui, TIAN Huijuan, ZHAI Yaling
Published: (2023-07-01)

Urinary peptidomics reveals proteases involved in idiopathic membranous nephropathy
by: Baoxu Lin, et al.
Published: (2021-11-01)

Editorial: Primary membranous nephropathy
by: Maria Infantino
Published: (2022-12-01)

Significance of thyroid dysfunction in the patients with primary membranous nephropathy
by: Qiu-hua Gu, et al.
Published: (2022-12-01)

Membranous Nephropathy (MN) Recurrence After Renal Transplantation
by: Patrizia Passerini, et al.
Published: (2019-06-01)

Efficacy and safety of two dose regimens of rituximab for idiopathic membranous nephropathy
by: Zhi-hui Tu, et al.
Published: (2024-02-01)

Idiopathic membranous nephropathy and anti-phospholipase A2 receptor antibodies
by: Ali Nayer, et al.
Published: (2013-10-01)

Efficacy of leflunomide combined with prednisone for the treatment of PLA2R-associated primary membranous nephropathy
by: Yaling Guo, et al.
Published: (2020-01-01)

Two cases of idiopathic membranous nephropathy treated with rituximab
by: Jae Young Yoon, et al.
Published: (2013-09-01)

The value of PLA2R antigen and IgG subclass staining relative to anti-PLA2R seropositivity in the differential diagnosis of membranous nephropathy
by: Dóra Bajcsi, et al.
Published: (2023-08-01)

Comparison of different therapies in high-risk patients with idiopathic membranous nephropathy
by: Lei Peng, et al.
Published: (2016-01-01)